与阿姆洛迪平相关的不良事件:使用FDA不良事件报告系统进行的药监测研究
Xingwei Di1, Jiazhen Jiang2, Qian Zhong3
1Department of Cardiovascular Medicine, The First Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, Guangdong, China.
Frontiers in cardiovascular medicine
|May 21, 2025
概括
阿姆洛迪平是一种常见的药物,可以引起严重的药物不良反应 (ADRs),如休克和牙增大. 医疗保健专业人员应仔细考虑这些风险,特别是在脆弱的患者群体中,以优化治疗结果.
科学领域:
- 药物监督 药物监督 药物监督
- 临床药理学 临床药理学
- 药品安全 药品安全
背景情况:
- 阿姆洛迪平是一种广泛使用的药物,已知药物不良反应 (ADRs) 可能会影响治疗的坚持和结果.
- 对阿姆洛迪平诱导的副作用的系统研究有限,这凸显了全面调查的需要.
- 了解阿姆洛迪平的ADR概况对于有效的患者管理和治疗优化至关重要.
研究的目的:
- 使用大规模的真实世界数据库,系统地识别和分析与阿姆洛迪平相关的不良药物反应 (ADR).
- 调查不同的人口分组 (性别和年龄) 的ADR概况的潜在差异.
- 通过统计方法验证已识别的不良反应,并确认阿姆洛迪平是独立的风险因素.
主要方法:
- 利用FDA不良事件报告系统 (FAERS) 数据库,专注于amlodipine是主要嫌疑人的报告.
- 采用了四种不同的风险信号检测算法:几率比率,比例报告比率,贝叶斯信任传播神经网络和经验贝叶斯几何平均值.
- 根据性别和年龄进行子组分析,并使用多变量逻辑回归进行验证.
主要成果:
- 在所有分析中,发现了大量的潜在的阿姆洛迪平相关的副作用,在多种方法中检测到27种常见的副作用.
- 确定的主要不良反应包括牙增大,血管综合征和分布性休克.
- 多变量逻辑回归证实了阿姆洛迪平是所有27种已识别的副作用的独立危险因子 (异常比率>1,P<0.05).
结论:
- 阿姆洛迪平与显著的风险有关,包括外周,休克和呼吸障碍,以及可能以前未报告的副作用,如异常的全血细胞计和人格障碍.
- 研究结果强调,在处方阿姆洛迪平时需要谨慎,特别是在高风险人群中.
- 这项研究为完善临床实践指南和改善阿姆洛迪平治疗患者安全提供了关键数据.
相关概念视频
Pharmacovigilance
763
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
763
Drug Regulation
1.3K
Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
1.3K
Local Anesthetics: Adverse Effects
385
While local anesthetics are generally safe and well-tolerated, they can occasionally cause adverse effects that vary in severity. Local anesthetics can induce toxicity at two distinct levels. They can either produce local effects through direct contact with the neural elements or be absorbed into the bloodstream from the injection site, leading to systemic effects.
Once absorbed into the systemic circulation, local anesthetics can affect the organs that depend on the functioning of sodium...
Once absorbed into the systemic circulation, local anesthetics can affect the organs that depend on the functioning of sodium...
385
Antihypertensive Drugs: Action of Calcium Channel Blockers
427
Calcium ions are essential to contract smooth muscle cells in blood vessels. They enter these cells through voltage-dependent calcium channels, specifically L-type calcium channels in the cell membrane. These L-type calcium channels are integral to the excitation-contraction coupling process in smooth muscle. When a stimulus is received by smooth muscle cells, their membrane depolarizes. This alteration in membrane potential instigates the opening of L-type calcium channels. As a result,...
427
Antiarrhythmic Drugs: Class IV Agents as Calcium Channel Blockers
746
Class IV antiarrhythmic drugs, such as verapamil and diltiazem, block calcium channels. They primarily affect the heart, slowing the conduction in calcium-dependent tissues like the SA and AV nodes. These drugs manage reentrant supraventricular tachycardia (SVT) and reduce ventricular rate in atrial flutter/fibrillation.
Verapamil, a calcium channel blocker, inhibits calcium movement across myocardial cell membranes and vascular smooth muscle. This results in the dilation of coronary and...
Verapamil, a calcium channel blocker, inhibits calcium movement across myocardial cell membranes and vascular smooth muscle. This results in the dilation of coronary and...
746
Antihypertensive Drugs: Angiotensin II Receptor Blockers
564
In the renin-angiotensin-aldosterone system, a hormone called angiotensin II plays a crucial role. It binds to the AT1 receptors in vascular smooth muscles coupled with Gq proteins. The activation of these receptors activates an enzyme called phospholipase C, which releases two molecules: inositol trisphosphate and diacylglycerol. These molecules cause a chain reaction that leads to the phosphorylation of myosin light chains and promotes interaction between actin and myosin, leading to smooth...
564


